Marketed By
bdr pharma
Pack of
14 Capsule(s) In A Strip
Salt Composition
Enzalutamide
Storage
Keep in cold place
Contact for Price
Bdenza 80mg capsule
Delivering To: —
All Substitutes
Overview
Bdenza 80 mg capsule is a prescription-based medication. Enzalutamide, an androgen receptor inhibitor classified as an antineoplastic medication, is the active ingredient in the capsule. This capsule should only be used by men; women should not use it without gloves, especially if they are pregnant.
Indication
Prostate Cancer
Uses
Advanced prostate cancer
Benefits
Side Effects
It is advised to use Bdenza 80 mg capsule as directed by the doctor. The common side effects of this tablet are:
Trouble breathing (pneumonia) feeling tired Back pain diarrhoea cold headache insomnia high blood pressure swelling in arms, legs, feet, or hand
How To Use
It is advised to use Bdenza 80 mg capsule as directed by the doctor. The common side effects of this tablet are:
Trouble breathing (pneumonia) feeling tired Back pain diarrhoea cold headache insomnia high blood pressure swelling in arms, legs, feet, or hand
How It Works
Bdenza 80 mg capsules should always be taken as prescribed by a doctor; they are not meant for self-medication. It can be taken with or without food as directed by the doctor. For optimal medication effectiveness, Bdenza 80 mg capsules must be swallowed rather than chewed, opened, or crushed. It is an oral medication used once a day at the same time every day, before meals. The Bdenza 80 mg capsule should be taken with at least an hour gap interval.
Safety Advice
Alcohol
consult your doctor
Pregnancy
consult your doctor
Breast Feeding
consult your doctor
Driving
unsafe
Kidney
safe if prescribed
Liver
safe if prescribed
Missed Doses
Quick Tips
FAQs
As soon as you remember, take the missed dose unless it's time for your next dose. You should never take a double dose to make up for a missed one.
Common side effects of the Bdenza 80 mg capsule are constipation, muscle pain, swelling, nausea, diarrhea, infection, loss of appetite, hair loss, vomiting, and weakness.
The doctor decides how long the treatment with the Bdenza 80 mg capsule will continue, depending on the stage and health of the patient.
It is advised not to take alcohol while taking the Bdenza 80mg capsule, because consuming alcohol can cause serious side effects and can damage your liver badly. Consult your doctor if you have concerns or queries.
During pregnancy, it is not safe to take Bdenza 80 mg capsule, as it can cause harm to the unborn baby. Furthermore, during breastfeeding, this medicine must not be used. Please make sure to consult your healthcare provider regarding the same.
Bdenza 80 mg blocks the androgen receptor due to the presence of enzalutamide. It blocks testosterone from reaching prostate cancer cells. Testosterone production helps cancer cells grow, so blocking its production can shrink cancer cell growth. Bdenza 40 mg belongs to the androgen receptor inhibitors.
Inform the doctor if you are allergic to the ingredient present in the Bdenza 80 mg capsule, in case of high sugar level, pregnancy or breastfeeding, or a weakened immune system. A patient with a medical history or medication must discuss it with a doctor.
No, Bdenza 80 mg capsule is an anti-cancer medication that contains enzalutamide, which is an androgen receptor inhibitor.
Bdenza 80 mg blocks the androgen receptor due to the presence of enzalutamide. It blocks testosterone from reaching prostate cancer cells. Testosterone production helps cancer cells grow, so blocking its production can shrink cancer cell growth. Bdenza 80mg belongs to the androgen receptor inhibitors.
Reference
Akaza, H., Uemura, H., Tsukamoto, T., Ozono, S., Ogawa, O., Sakai, H., & Naito, S. (2024). A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer. International Journal of Clinical Oncology, 21(4), 773-782.
Golshayan, A. R., & Antonarakis, E. S. (2023). Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer. Core evidence, 27-35.
Hori, A., Sahashi, H., Sano, S., Matsumiya, E., Ariga, M., Asano, A., & Kitaichi, K. (2020). Efficacy and safety of enzalutamide in a real-world cohort of Japanese patients with castration-resistant prostate cancer. Anticancer Research, 40(12), 7101-7108.
Miura, R., Hirabatake, M., Irie, K., Ikesue, H., Muroi, N., Kawakita, M., & Hashida, T. (2021). Safety evaluation of enzalutamide dose-escalation strategy in patients with castration-resistant prostate cancer. In Urologic Oncology: Seminars and Original Investigations (Vol. 39, No. 4, pp. 233-e15). Elsevier.
Vinh-Hung, V., Natchagande, G., Joachim, C., Gorobets, O., Drame, M., Bougas, S. & Yin, M. (2020). Low-dose enzalutamide in late-elderly patients (≥ 75 years old) presenting with metastatic castration-resistant prostate cancer. Clinical genitourinary cancer, 18(6), e660-e668.
Ratings And Reviews
5.00/5
5 Ratings
5 Star
100.00%
4 Star
0.00%
3 Star
0.00%
2 Star
0.00%
1 Star
0.00%
Robert Thompson
Great product for daily use
a year ago
Siddharth P.
Exceeded my expectations
a year ago
View All Reviews
Related Products
MARKETER DETAILS
bdr pharma
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.